Pathophysiological Analysis of Prion Protein Expression in the Liver
Pathophysiological Analysis of Prion Protein Expression in the Liver
批准号:
11670525
负责人:
KAWADA Norifumi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
我们用PCR-selectcDNA消减法发现了活化星状细胞中朊蛋白基因的表达。北方印迹分析表明,PrP mRNA几乎不表达在静止的星状细胞,但其表达显着增强在一个激活的表型。Western blot分析还显示PrP表达以时间依赖性方式增强。原位杂交和免疫组化检测到PrP及其mRNA在肝纤维化模型中的表达,尤其是纤维化隔沿着的细胞外基质物质和平滑肌α-肌动蛋白阳性细胞的表达。此外,PrP的表达被证实在人类患病的肝组织与HBV和HCV诱导的慢性病毒性肝炎和酒精性肝损伤。PrP表达与炎症程度呈正相关。进一步的分析表明PrP的表达与平滑肌α-actin的表达共定位,表明PrP主要在星状细胞中表达。这些结果表明,PrP将作为一种新的肝纤维化的标志物在临床领域。
英文摘要
We have discovered the prion protein (PrP) gene expression in activated stellate cells by using PCR-select cDNA subtraction method. Northern blot analysis revealed that PrP mRNA was hardly expressed in quiescent stellate cells, but its expression was dramatically augmented in an activated phenotype. Western blot analysis also revealed that PrP expression was enhanced in a time-dependent manner. In in situ hybridization and in imunohistochemistry, PrP and its mRNA expression was detected in liver fibrosis model, in particular along the fibrotic septum accumulating extracellular matrix materials and smooth muscle α-actin-positive cells. In addition, PrP expression was confirmed in human diseased liver tissue with HBV and HCV-induced chronic viral hepatitis and alcoholic liver damage. PrP expression had positive relationship with inflammatory severity. Further analysis indicated that PrP expression was co-localized with the expression of smooth muscle α-actin, indicating that PrP was expressed dominantly in stellate cells. These results indicate that PrP would be utilized as a novel marker for liver fibrosis in the clinical field.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Horie T, Amagaya S, Kawada N, Hori H, Ito S.: "Effects of sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats"Hepatology. 29. 149-160 (1999)
Horie T、Amagaya S、Kawada N、Hori H、Ito S.:“日本草药 sho-saiko-to 对大鼠肝纤维化的影响”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawada N, et al.: "cycclin expression correlate with stellate cell proliferation"J. Hepatology. 30. 1057-1064 (1999)
Kawada N 等人:“细胞周期蛋白表达与星状细胞增殖相关”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kitada T,Seki S. et al.: "Clinicopathological characterization of prions a novel marker of human activated stellate"J.Hepatol. 33. 751-757 (2000)
Kitada T,Seki S. 等人:“朊病毒的临床病理学特征,一种人类激活星状蛋白的新标记”J.Hepatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okumo M,Akita K,Moriwaki H,Kawada N.: "Prevention of rat hepatic fibrosis by the protease inhibitor cameostert…"Gastroenterology.. (in press). (2001)
Okumo M、Akita K、Moriwaki H、Kawada N.:“蛋白酶抑制剂卡莫斯特预防大鼠肝纤维化……”胃肠病学..(印刷中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seki S, Sakaguchi H, Kitada T, Tamori A, Takeda T, Kawada N, Habu D, Nakatani K, Nishiguchi S, Shiomi S.: "Outcomes of dysplastic nodules in human cirrhotic liver : A clinicopathological study."Clin.Cancer Res.. 9. 3469-3473 (2000)
Seki S、Sakaguchi H、Kitada T、Tamori A、Takeda T、Kawada N、Habu D、Nakatani K、Nishiguchi S、Shiomi S.:“人类肝硬化肝脏发育不良结节的结果:一项临床病理学研究。”Clin.Cancer Res
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Involvement of cytoglobin-expressing mesenchymal cells in cancer development
-
批准号:22650224
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.13万
-
财政年份:2010
-
负责人:KAWADA Norifumi
-
依托单位:
Analyses of the development of liver cancer and cirrhosis by using cytoglobin-deficient mice
-
批准号:21390232
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.74万
-
财政年份:2009
-
负责人:KAWADA Norifumi
-
依托单位:
Functional analysis of cytoglobin that is expressed and induced in liver cirrhosis
-
批准号:16590618
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2004
-
负责人:KAWADA Norifumi
-
依托单位:
Functional analysis of stap, a novel gene expressed in hepatic stellate cells and fibrotic liver tissue and its significance in clinicopathophysiology
-
批准号:14570497
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2002
-
负责人:KAWADA Norifumi
-
依托单位:
海外基金